Informações de Elevance Health Inc | Histórico, dados financeiros e desempenho de mercado

Informações de Elevance Health Inc Empresa

Elevance Health, Inc. is a health company. It operates as a health insurer in the United States. The Company operates through four segments: Health Benefits, CarelonRx, Carelon Services and Corporate & Other. The Health Benefits segment offers a comprehensive suite of health plans and services to its Individual, Employer Group risk-based, Employer Group fee-based, BlueCard, Medicare, Medicaid and Federal Employee Program (FEP) members. The Health Benefits segment also offers health products on a full-risk basis. The CarelonRx segment includes its pharmacy services business. CarelonRx markets and offers pharmacy services to its affiliated health plan customers, as well as to external customers outside of the health plans. The Carelon Services segment integrates physical, behavioral, pharmacy, and social services by offering an array of healthcare-related services and capabilities to internal and external customers through its Carelon Health and Carelon Insights businesses.

Informações da empresa

Código da empresaELV

Nome da EmpresaElevance Health Inc

Data de listagemOct 30, 2001

Fundado em2001

CEOMs. Gail K. Boudreaux

Funcionários103158

Tipo de TítulosOrdinary Share

Fim do ano fiscalOct 30

Endereço220 Virginia Avenue

CidadeINDIANAPOLIS

Bolsa de ValoresNYSE Consolidated

PaísUnited States of America

Código postal46204

Telefone18003311476

Sitehttps://www.elevancehealth.com/

Código da empresaELV

Data de listagemOct 30, 2001

Fundado em2001

Executivos da Empresa

Nome

Nome/Posição

Posição

Ações Detidas

Variação

Ms. Gail K. Boudreaux

President, Chief Executive Officer, Director

149.75K

+11.80%

Tallett (Elizabeth E)

Independent Chairman of the Board

10.29K

--

Mr. Ramiro G. Peru

Independent Chairman of the Board

8.74K

--

Mr. Antonio F. Neri

Independent Director

4.32K

--

Dr. Bahija Jallal, Ph.D.

Independent Director

4.19K

--

Mr. Ronald W. Penczek

Chief Accounting Officer, Controller

1.69K

+3.99%

Ms. Deanna D. Strable-Soethout

Independent Director

1.04K

--

Mr. Charles Morgan Kendrick, Jr.

Executive Vice President and President, Commercial and Specialty Health Benefits

--

Mr. Robert L. Dixon, Jr.

Independent Director

--

Ms. Felicia F. Norwood

Executive Vice President and President, Government Health Benefits

--

Ver Mais

Nome

Nome/Posição

Posição

Ações Detidas

Variação

Ms. Gail K. Boudreaux

President, Chief Executive Officer, Director

149.75K

+11.80%

Tallett (Elizabeth E)

Independent Chairman of the Board

10.29K

--

Mr. Ramiro G. Peru

Independent Chairman of the Board

8.74K

--

Mr. Antonio F. Neri

Independent Director

4.32K

--

Dr. Bahija Jallal, Ph.D.

Independent Director

4.19K

--

Mr. Ronald W. Penczek

Chief Accounting Officer, Controller

1.69K

+3.99%

Detalhamento da Receita

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021

FY2020

FY2019

FY2018

Por EmpresaUSD

Nome

Receita

Proporção

Premiums

144.17B

0.00%

Product revenue

22.63B

0.00%

Service fees

8.41B

0.00%

Reconciliation

1.81B

0.00%

Operating revenue - affliated

0.00

0.00%

Sem dados

Por Empresa

Por Região

Por EmpresaUSD

Nome

Receita

Proporção

Premiums

144.17B

0.00%

Product revenue

22.63B

0.00%

Service fees

8.41B

0.00%

Reconciliation

1.81B

0.00%

Operating revenue - affliated

0.00

0.00%

Acionista

Tempo de atualização: há 18 horas

Estatísticas do Acionista

Tipo

Estatísticas do Acionista

Acionista

Proporção

The Vanguard Group, Inc.

9.45%

BlackRock Institutional Trust Company, N.A.

5.20%

State Street Global Advisors (US)

4.72%

T. Rowe Price Associates, Inc.

4.52%

Wellington Management Company, LLP

2.81%

Other

73.30%

Estatísticas do Acionista

Acionista

Proporção

The Vanguard Group, Inc.

9.45%

BlackRock Institutional Trust Company, N.A.

5.20%

State Street Global Advisors (US)

4.72%

T. Rowe Price Associates, Inc.

4.52%

Wellington Management Company, LLP

2.81%

Other

73.30%

Tipo

Acionista

Proporção

Investment Advisor

43.71%

Investment Advisor/Hedge Fund

40.97%

Pension Fund

2.64%

Hedge Fund

2.62%

Bank and Trust

2.51%

Research Firm

1.81%

Sovereign Wealth Fund

1.45%

Family Office

0.27%

Family Office

0.27%

Other

3.74%

Instituição Participações

Tempo de atualização: dom, 19 de jan

Período do Relatório

Nº de instituições

Ações detidas

Proporção

Variação

2025Q1

3022

212.89M

94.03%

-4.73M

2024Q4

3098

213.30M

93.78%

-5.08M

2024Q3

3004

212.78M

91.75%

-6.27M

2024Q2

2973

214.50M

92.28%

-4.31M

2024Q1

2940

212.64M

91.38%

-6.83M

2023Q4

2879

214.42M

91.26%

-6.60M

2023Q3

2767

215.95M

91.62%

-5.63M

2023Q2

2750

218.40M

92.12%

-4.32M

2023Q1

2729

219.91M

92.66%

-8.42M

2022Q4

2684

220.86M

92.46%

-8.53M

Ver Mais

Atividade dos Acionistas

Nome

Ações detidas

Proporção

Variação

Chg %

Data

The Vanguard Group, Inc.

21.38M

9.45%

+141.85K

+0.67%

Dec 31, 2024

BlackRock Institutional Trust Company, N.A.

11.78M

5.2%

+200.94K

+1.74%

Dec 31, 2024

State Street Global Advisors (US)

10.68M

4.72%

-5.71K

-0.05%

Dec 31, 2024

T. Rowe Price Associates, Inc.

10.24M

4.52%

+459.21K

+4.70%

Dec 31, 2024

Wellington Management Company, LLP

6.36M

2.81%

+1.89M

+42.45%

Dec 31, 2024

Geode Capital Management, L.L.C.

4.96M

2.19%

+115.97K

+2.39%

Dec 31, 2024

Sanders Capital, LLC

4.69M

2.07%

+76.90K

+1.67%

Dec 31, 2024

Capital International Investors

3.88M

1.71%

+35.58K

+0.93%

Dec 31, 2024

First Eagle Investment Management, L.L.C.

3.23M

1.42%

+1.04M

+47.56%

Dec 31, 2024

Ver Mais

ETFs Relacionados

Tempo de atualização: dom, 6 de abr

Nome

Proporção

iShares U.S. Healthcare Providers ETF

12.36%

Monarch Dividend Plus Index ETF

3.5%

First Eagle Global Equity ETF

3.41%

Brookstone Value Stock ETF

3.3%

GMO US Quality ETF

3.1%

Simplify Market Neutral Equity Long/Short ETF

3.07%

Eagle Capital Select Equity ETF

2.62%

NYLI Healthy Hearts ETF

2.6%

Invesco S&P 500 Enhanced Value ETF

2.26%

FT Cboe Vest Rising Dividend Achievers Target Inc

2.21%

Ver Mais

iShares U.S. Healthcare Providers ETF

Proporção12.36%

Monarch Dividend Plus Index ETF

Proporção3.5%

First Eagle Global Equity ETF

Proporção3.41%

Brookstone Value Stock ETF

Proporção3.3%

GMO US Quality ETF

Proporção3.1%

Simplify Market Neutral Equity Long/Short ETF

Proporção3.07%

Eagle Capital Select Equity ETF

Proporção2.62%

NYLI Healthy Hearts ETF

Proporção2.6%

Invesco S&P 500 Enhanced Value ETF

Proporção2.26%

FT Cboe Vest Rising Dividend Achievers Target Inc

Proporção2.21%

Dividendo

Um total de 6.19B USD foi distribuído em dividendos nos últimos 5 anos.

Data

Dividendo

Data de registro das ações

Data de pagamento

Data de ex-dividendo

Jan 23, 2025

ELV.NB Interim Cash Dividend of gross USD 1.71 paid on Mar 25, 2025 going ex on Mar 10, 2025

Mar 10, 2025

Mar 25, 2025

Mar 10, 2025

Oct 17, 2024

ELV.NB Final Cash Dividend of gross USD 1.63 paid on Dec 20, 2024 going ex on Dec 05, 2024

Dec 05, 2024

Dec 20, 2024

Dec 05, 2024

Jul 17, 2024

ELV.NB Interim Cash Dividend of gross USD 1.63 paid on Sep 25, 2024 going ex on Sep 10, 2024

Sep 10, 2024

Sep 25, 2024

Sep 10, 2024

Apr 18, 2024

ELV.NB Interim Cash Dividend of gross USD 1.63 paid on Jun 25, 2024 going ex on Jun 10, 2024

Jun 10, 2024

Jun 25, 2024

Jun 10, 2024

Jan 26, 2024

ELV.NB Interim Cash Dividend of gross USD 1.63 paid on Mar 22, 2024 going ex on Mar 07, 2024

Mar 08, 2024

Mar 22, 2024

Mar 07, 2024

Oct 18, 2023

ELV.NB Final Cash Dividend of gross USD 1.48 paid on Dec 21, 2023 going ex on Dec 05, 2023

Dec 06, 2023

Dec 21, 2023

Dec 05, 2023

Jul 19, 2023

ELV.NB Interim Cash Dividend of gross USD 1.48 paid on Sep 22, 2023 going ex on Sep 07, 2023

Sep 08, 2023

Sep 22, 2023

Sep 07, 2023

Apr 19, 2023

ELV.NB Interim Cash Dividend of gross USD 1.48 paid on Jun 23, 2023 going ex on Jun 08, 2023

Jun 09, 2023

Jun 23, 2023

Jun 08, 2023

Jan 25, 2023

ELV.NB Interim Cash Dividend of gross USD 1.48 paid on Mar 24, 2023 going ex on Mar 09, 2023

Mar 10, 2023

Mar 24, 2023

Mar 09, 2023

Oct 19, 2022

ELV.NB Final Cash Dividend of gross USD 1.28 paid on Dec 21, 2022 going ex on Dec 02, 2022

Dec 05, 2022

Dec 21, 2022

Dec 02, 2022

Ver Mais

Desdobramento de Ações

Data

Tipo

Proporção

Sem dados

Data

Tipo

Proporção

Sem dados

Elevance Health Inc

424.550USD

Elevance Health Inc

424.550

Visão Geral

Empresa